Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Wisp, a virtual provider of sexual and reproductive health services, is launching a new weight care vertical to help women struggling with hormonal imbalances
Eli Lilly is targeting an FDA submission for retatrutide in late 2026, after the largest of its Phase 3 trials are published
2, the meta-analysis of all available cohorts showed a significant reduction in risk for schizophrenia (OR = 0.72, 95% CI [0.610.86]), bipolar disorder (OR = 0.91, 95% CI [0.880.94]), bulimia nervosa (OR = 0.34, 95% CI [0.230.52]), PTSD (OR = 0.45, 95% CI [0.310.67]), and autism (OR = 0.55, 95% CI [0.320.93])
Establishing transparency and reporting requirements for PBMs will include data on utilization, pricing, and revenues for formulary covered drugs
Readers should understand that compounded GLP-1 availability may depend on current federal policy, state rules, individual pharmacy requirements, current shortage status, and clinician judgment
US$ 26.31
US$ 24.86
US$ 22.79
US$ 22.05
US$ 28.34
US$ 23.26
US$ 20.60
US$ 29.37
US$ 20.72
US$ 27.01
US$ 25.32
